Loading...
Loading...
PEARW| Name | Value |
|---|---|
| Revenues | 2.7M |
| Cost of Revenue | 1.5M |
| Gross Profit | 1.3M |
| Operating Expense | 36.0M |
| Operating I/L | -34.7M |
| Other Income/Expense | 10.9M |
| Interest Income | 0.0M |
| Pretax | -23.9M |
| Income Tax Expense | -10.9M |
| Net Income/Loss | -13.0M |
Pear Therapeutics, Inc. specializes in developing and commercializing software-based medicines for severe psychiatric and neurologic conditions. Their products include PearConnect, a patient service center for prescription digital therapeutics; reSET for substance use disorder treatment; reSET-O for opioid use disorder treatment; and Somryst for chronic insomnia treatment.
